The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
South and Central America are seeing the most growth, with North America and Europe close behind.
There is still much to learn about the benefits and potential of robotic surgery.
Several technologies that can streamline procedures for surgeons in the OR are in development.
Surgeons recently demonstrated that autonomous robotic soft tissue surgery outperforms standard clinical methods.